Arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillation

Atrial fibrillation (AF) often requires invasive treatment by ablation to decrease symptom burden. The pulmonary veins (PV) are thought to trigger paroxysms of AF, and ablative PV isolation (PVI) is a cornerstone in AF treatment. However, incomplete PVI, where electrical conduction between the PV an...

Full description

Bibliographic Details
Main Authors: Lisa A. Gottlieb, Lukas R. C. Dekker, Ruben Coronel
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2023.1157338/full
_version_ 1797821505906671616
author Lisa A. Gottlieb
Lisa A. Gottlieb
Lisa A. Gottlieb
Lukas R. C. Dekker
Lukas R. C. Dekker
Ruben Coronel
Ruben Coronel
author_facet Lisa A. Gottlieb
Lisa A. Gottlieb
Lisa A. Gottlieb
Lukas R. C. Dekker
Lukas R. C. Dekker
Ruben Coronel
Ruben Coronel
author_sort Lisa A. Gottlieb
collection DOAJ
description Atrial fibrillation (AF) often requires invasive treatment by ablation to decrease symptom burden. The pulmonary veins (PV) are thought to trigger paroxysms of AF, and ablative PV isolation (PVI) is a cornerstone in AF treatment. However, incomplete PVI, where electrical conduction between the PV and left atrium (LA) is maintained, is curative of AF in a subset of patients. This implies that an antiarrhythmic effect other than electrical isolation between the PV and LA plays a role in AF prevention in these patients. We reason that the PV myocardium constitutes an arrhythmogenic substrate conducive to reentry in the patients with curative incomplete PVI. This PV substrate is amenable to ablation, even when conduction between the LA and PV persists. We propose that PV ablation strategies are differentiated to fit the arrhythmogenic mechanisms in the individual patient. PV substrate modification in patients with PV reentry may constitute a new therapeutic approach that is potentially simpler and more effective, in this subgroup of patients.
first_indexed 2024-03-13T09:53:40Z
format Article
id doaj.art-86ec041957af4c7dabd45d5b2a5ce11d
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-03-13T09:53:40Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-86ec041957af4c7dabd45d5b2a5ce11d2023-05-24T04:38:37ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2023-05-011410.3389/fphys.2023.11573381157338Arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillationLisa A. Gottlieb0Lisa A. Gottlieb1Lisa A. Gottlieb2Lukas R. C. Dekker3Lukas R. C. Dekker4Ruben Coronel5Ruben Coronel6Department of Cardiology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, DenmarkElectrophysiology and Heart Modeling Institute, University of Bordeaux, Bordeaux, FranceAmsterdam UMC, location Academic Medical Centre, Department of Experimental Cardiology, University of Amsterdam, Amsterdam, NetherlandsDepartment of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, NetherlandsDepartment of Cardiology, Catharina Hospital, Eindhoven, NetherlandsElectrophysiology and Heart Modeling Institute, University of Bordeaux, Bordeaux, FranceAmsterdam UMC, location Academic Medical Centre, Department of Experimental Cardiology, University of Amsterdam, Amsterdam, NetherlandsAtrial fibrillation (AF) often requires invasive treatment by ablation to decrease symptom burden. The pulmonary veins (PV) are thought to trigger paroxysms of AF, and ablative PV isolation (PVI) is a cornerstone in AF treatment. However, incomplete PVI, where electrical conduction between the PV and left atrium (LA) is maintained, is curative of AF in a subset of patients. This implies that an antiarrhythmic effect other than electrical isolation between the PV and LA plays a role in AF prevention in these patients. We reason that the PV myocardium constitutes an arrhythmogenic substrate conducive to reentry in the patients with curative incomplete PVI. This PV substrate is amenable to ablation, even when conduction between the LA and PV persists. We propose that PV ablation strategies are differentiated to fit the arrhythmogenic mechanisms in the individual patient. PV substrate modification in patients with PV reentry may constitute a new therapeutic approach that is potentially simpler and more effective, in this subgroup of patients.https://www.frontiersin.org/articles/10.3389/fphys.2023.1157338/fullablationfocal arrhythmiasparoxysmal atrial fibrillationpulmonary veinpulmonary vein isolationreentry
spellingShingle Lisa A. Gottlieb
Lisa A. Gottlieb
Lisa A. Gottlieb
Lukas R. C. Dekker
Lukas R. C. Dekker
Ruben Coronel
Ruben Coronel
Arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillation
Frontiers in Physiology
ablation
focal arrhythmias
paroxysmal atrial fibrillation
pulmonary vein
pulmonary vein isolation
reentry
title Arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillation
title_full Arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillation
title_fullStr Arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillation
title_full_unstemmed Arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillation
title_short Arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillation
title_sort arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillation
topic ablation
focal arrhythmias
paroxysmal atrial fibrillation
pulmonary vein
pulmonary vein isolation
reentry
url https://www.frontiersin.org/articles/10.3389/fphys.2023.1157338/full
work_keys_str_mv AT lisaagottlieb arrhythmiamechanismdependentpulmonaryveinablationinparoxysmalatrialfibrillation
AT lisaagottlieb arrhythmiamechanismdependentpulmonaryveinablationinparoxysmalatrialfibrillation
AT lisaagottlieb arrhythmiamechanismdependentpulmonaryveinablationinparoxysmalatrialfibrillation
AT lukasrcdekker arrhythmiamechanismdependentpulmonaryveinablationinparoxysmalatrialfibrillation
AT lukasrcdekker arrhythmiamechanismdependentpulmonaryveinablationinparoxysmalatrialfibrillation
AT rubencoronel arrhythmiamechanismdependentpulmonaryveinablationinparoxysmalatrialfibrillation
AT rubencoronel arrhythmiamechanismdependentpulmonaryveinablationinparoxysmalatrialfibrillation